Marcus A. Conant
Corporate Officer/Principal bei The University of California, San Francisco
Aktive Positionen von Marcus A. Conant
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Karriereverlauf von Marcus A. Conant
Ehemalige bekannte Positionen von Marcus A. Conant
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| ENZO BIOCHEM, INC. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Marcus A. Conant
- Erfahrung